APPLE AND JOHNSON & JOHNSON LAUNCH DIGITAL HEALTH STUDY
by John G. Baresky on 02/26/20
A large scale digital health initiative
Apple and Johnson & Johnson have launched a new study to detect atrial fibrillation among seniors while promoting wellness and pro-active heart health.
The clinical study
focuses on Atrial Fibrillation
Atrial fibrillation (referred to as "A-fib") is a cardiovascular issue which may increase the risk of strokes and other serious heart-related problems.
Patients over age 65 can pick up a discounted Apple Watch ($49 plus applicable sales tax) at a Best Buy store if they are assigned one for the study or are issued an iPhone app called Heartline which also connects to Medicare’s Blue Button API that provides the patients access to their Medicare billing and claims data.
This unique study is one
of the largest randomized digital health trials in history, at a minimum, the goal
is to recruit 150,000 people.
Collaborating Technology, Clinical and Retail Partners
Its working model is
unique in that it represents a partnership between a technology company (Apple,
NASDAQ: AAPL), a global healthcare conglomerate (Johnnson & Johnson, NYSE:
JNJ) and a retailer (Best Buy, NYSE: BBY) to facilitate the study program.
